OCHIAI, T., NISHIMURA, K., WATANABE, T., KITAJIMA, M., NAKATANI, A., INOU, T., . . . NAGAOKA, I. (2013). Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs. D.A. Spandidos.
Chicago Style CitationOCHIAI, TAKUMI, et al. Serum Iron Levels As a New Biomarker in Chemotherapy With Leucovorin and Fluorouracil Plus Oxaliplatin or Leucovorin and Fluorouracil Plus Irinotecan, With or Without Molecularly-targeted Drugs. D.A. Spandidos, 2013.
Cita MLAOCHIAI, TAKUMI, et al. Serum Iron Levels As a New Biomarker in Chemotherapy With Leucovorin and Fluorouracil Plus Oxaliplatin or Leucovorin and Fluorouracil Plus Irinotecan, With or Without Molecularly-targeted Drugs. D.A. Spandidos, 2013.